BIOX Earnings & Financial Statements
Bioceres Crop Solutions Corp.
$0.23
+$0.02(+10.19%)
40
Overall
60
Value
18
Tech
44
Quality
Market Cap
$14.94M
Volume
244.86K
52W Range
$0.19 - $2.03
Target Price
$2.00
BIOX earnings and financial statements: Bioceres Crop Solutions Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly.
BIOX Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $238.28M | $289.43M | $464.87M | $419.45M | $43.34M |
| Cost of revenue | $155.10M | $184.38M | $278.22M | $235.46M | $10.16M |
| Operating income | -$11.23M | -$26.15M | $37.86M | $57.83M | $6.43M |
| EBITDA | -$19.77M | -$18.80M | $54.22M | $36.24M | $8.78M |
| Net income | -$76.65M | -$58.22M | $5.29M | -$9.41M | $5.52M |
| EPS (diluted) | $-1.20 | $-0.72 | $0.07 | $0.30 | $-0.09 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $448.23M | $763.65M | $852.55M | $818.06M | $69.04M |
| Total liabilities | $414.17M | $468.43M | $501.17M | $487.56M | $53.84M |
| Shareholders’ equity | $10.72M | $265.44M | $315.04M | $298.59M | $15.20M |
| Cash and equivalents | $11.24M | $32.70M | $44.47M | $48.13M | $3.75M |
| Long-term debt | $68.76M | $47.73M | $131.08M | $145.91M | $9.30M |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $66.01M | $49.91M | $41.72M | $2.59M | -$9.98M |
| Capital expenditure | - | - | - | - | -$614.0K |
| Free cash flow | $62.39M | $39.04M | $18.93M | -$19.84M | -$10.59M |
| Dividends paid | - | $72.1K | $174.8K | $452.1K | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIOX | $0.23 | +10.2% | 244.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bioceres Crop Solutions Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW